← Open Payments lookup

PETER GOLDEN: Open Payments

NPI 1588867626 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,213 in 309 payments from 19 companies in 2025. Trend: 2023 $2,917 · 2024 $4,804 · 2025 $5,213

Food & beverage: $5,102Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.62$1,278
E.R. Squibb & Sons, L.L.C.31$597
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$382
Alkermes, Inc.22$357
ABBVIE INC.26$348
Supernus Pharmaceuticals, Inc.35$328
Teva Pharmaceuticals USA, Inc.7$320
Neurocrine BioSciences, Inc.8$273
Vanda Pharmaceuticals Inc.13$235
Lundbeck LLC11$210

Products named: REXULTI, COBENFY, CAPLYTA, VRAYLAR, Qelbree, ARISTADA, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across OH — which companies pay providers there.